$CME

CME Group Posts Record Q3 Revenue of $1.74 Billion, Net Income of $1.04 Billion

CME Group reported Q3 revenue of $1.74B, up 13% YoY, with net income of $1.04B. Record trading volumes and market volatility drove growth, according to the company. CME returned $1B to shareholders and holds $2.4B in cash.

Original reporting
Published Oct 23, 2026, 1:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 23, 2026, 1:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CME Group Posts Record Q3 Revenue of $1.74 Billion, Net Income of $1.04 Billion — source image
Decision brief

The 30-second read

$CMEBullishHigh
01

Why it matters

Record Q3 earnings reflect heightened market volatility and trading activity, reinforcing CME’s central role in risk management.

02

Market read

CME’s earnings beat underscores strong demand for derivatives amid volatility, likely buoying its stock and related financial‑services equities.

03

What to watch

The report does not include forward guidance; any slowdown in volatility could temper the rally.

Relevance 8/10Novelty 8/10Timing: post‑market today

Background

CME Group is the world’s largest derivatives exchange, providing clearing and market‑data services across asset classes.

Company-level read

Ticker impact

$CMEBullishHigh confidence
Context

CME Group reported record Q3 revenue of $1.74 B and net income of $1.04 B, the first disclosure of these earnings figures.

Expected impact

potential upside as market prices in the record revenue and earnings beat

Evidence & confidence

Record revenue and net income exceed prior-year levels; no guidance provided but the magnitude suggests better-than-expected performance.

Market effects

Derivatives and market‑data providers may see increased demand, supporting related stocks.

U.S. financial‑services sector could benefit from CME's strong results.

CME's global clearing volume growth signals broader market volatility, relevant for worldwide traders.

Counterpoint

If expectations were already high, the results may be priced in, limiting upside.

Key entities

  • Terry Duffy

    Chairman and CEO of CME Group, quoted on market uncertainty driving demand.

Related articles

$CMEMedAI 9/10

Key facts: CME Q3 Up; Adds BCH & UNI Futures; Crypto Revenue Embedded

CME Group (CME) reported Q3 2026 revenue of $1.74B (+13%), net income of $1.04B, and diluted EPS of $2.89 (+16%). The company launched Bitcoin Cash and Uniswap futures on Oct 19, 2026, and noted record average daily volume. Crypto revenue is embedded within broader market activities. CME also highlighted regional copper pricing divergences and 24/7 crypto trading volumes.

$CMEMedAI 8/10

CME Posts Record Q3 Revenue As Crypto Derivatives Push Continues

CME Group reported record Q3 revenue of $1.74B, up 13% YoY, with average daily volume at 29.4M contracts. Market-data revenue reached $243M. The company expanded its crypto offerings, announcing Bitcoin Cash and Uniswap futures, but did not disclose crypto-specific revenue. According to CME, first-half crypto derivatives volume averaged 279,800 contracts, with $8.3B in notional value.

$CMEMed

CME Maintained by Barclays -- Price Target Raised to $321

Barclays maintained an Equal-Weight rating on CME Group (CME) but raised its price target to $321 from $281. CME's stock is currently priced at $305.65, which is 10.8% overvalued according to its GF Value™ of $275.98. The company has a GF Score™ of 88/100, indicating strong performance in profitability and growth. 19 gurus hold CME, with 12 adding to their positions recently.

$CMEMed

CME Maintained by Wells Fargo -- Price Target Raised to $333

Wells Fargo maintained an Overweight rating for CME Group and raised its price target to $333 from $315. CME operates the world's largest derivatives marketplace. GuruFocus values CME at $275.98, indicating a 10.9% overvaluation at its current price of $306.07. The company has a GF Score of 88, with strong growth and profitability metrics.